Home Recalls D-0206-2023
Class II · Moderate risk Terminated Initiated Dec 22, 2022 (4 years ago)
Estradiol Cyp/Test Cyp- Ss Oil- 2mg/50mg/Ml (1.5ml Vial) Injectable; Estradiol Cyp/Test…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
What was recalled
ESTRADIOL CYP/TEST CYP- SS OIL- 2MG/50MG/ML (1.5ML VIAL) INJECTABLE; ESTRADIOL CYP/TEST CYP -SS OIL- 2MG/25MG/ML (1ML VIAL) INJECTABLE; ESTRADIOL CYP-CS OIL- 5MG/ML (1.25ML VIAL) INJECTABLE; ESTRADIOL CYP-GS OIL- 5MG/ML (1ML VIAL) INJECTABLE ESTRADIOL CYP-SS OIL- 5MG/ML (1.5ML VIAL) INJECTABLE; ESTRADIOL CYP-SS OIL- 5MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Recalling firm Pharmacy Innovations
Origin PA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0206-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing May 27, 2026
Reason Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Class II · Moderate risk Ongoing May 12, 2026
Reason Defective Container; packets were found to be either empty or partially full.
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter
Class II · Moderate risk Ongoing Jan 26, 2026
Reason Presence of Foreign substance - potential presence of metal particulate matter